Health and biotech

Betta Pharmaceuticals贝达药业

Standard profile, compiled by hangzhou.be from public sourcescancer drugslung cancertargeted therapybiotech

About the company

Betta Pharmaceuticals develops and sells cancer drugs, led by icotinib (Conmana), a targeted therapy for lung cancer. It was founded in Hangzhou in January 2003 by a team of returnee scientists including Ding Lieming and Wang Yinxiang, and has its headquarters in the Yuhang Economic and Technological Development Zone. Icotinib, approved in China in June 2011, is described as the country’s first domestically developed targeted anti-cancer drug. Betta has been listed on Shenzhen’s ChiNext board since November 2016.

Video

No video yet. A company video is an add-on for companies with a profile.

Presentation

No presentation yet. A company presentation is an add-on for companies with a profile.

News

No news yet. Once the company claims its profile, hangzhou.be follows the news on the company website and whatever the company approves appears here.

Partnerships on hangzhou.be

No confirmed partnerships yet. A partnership only appears once both companies confirm it.